Krilogy Financial Portfolio holdings
Krilogy is a wealth management firm that has added a tax practice, a law practice and a retirement plan group alongside its investment services. Krilogy Tax came in 2017, Krilogy Law in 2020, and (K) Plans, which works only with company retirement plans, followed after that. Kent Skornia is its president and chief executive. Its core investment philosophy is long-term, and it serves high and ultra-high net worth individuals and families, retirement plans, charities, foundations and businesses. Through its Krilogy Portfolio Services division, it also supplies investment management and research to other advisers and their clients.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$110M |
| 2 |
iShares iBonds Dec 2056 Term Treasury ETF
IBGM
|
+$37.8M |
| 3 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
+$30.1M |
| 4 |
iShares iBonds Dec 2046 Term Treasury ETF
IBGC
|
+$20.2M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$31.3M |
| 2 |
Dimensional US Core Equity Market ETF
DFAU
|
+$15.2M |
| 3 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$12.6M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$11M |
| 5 |
VanEck Agribusiness ETF
MOO
|
+$9.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.73% |
| 2 | Technology | 12.03% |
| 3 | Industrials | 7.44% |
| 4 | Financials | 4.01% |
| 5 | Healthcare | 3.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Acacia Research
ACTG
$422M
| $5.59M | 0.15% |
1,287,657
+159,826
| +14% | +$722K |
2022 Q4
15 quarters
|
|
102
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.22B
| $5.4M | 0.15% |
219,882
+14,960
| +7% | +$378K |
2024 Q1
10 quarters
|
|
103
Uber
UBER
$144B
| $5.4M | 0.15% |
75,513
-7,876
| -9% | -$576K |
2021 Q3
20 quarters
|
|
104
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.73B
| $5.38M | 0.15% |
267,801
+96
| +0% | +$1.97K |
2022 Q1
18 quarters
|
|
105
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$915M
| $5.38M | 0.15% |
218,103
+16,176
| +8% | +$412K |
2024 Q4
7 quarters
|
|
106
iShares Russell 1000 Growth ETF
IWF
$117B
| $5.38M | 0.15% |
42,320
-2,563
| -6% | -$314K |
2025 Q3
4 quarters
|
|
107
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.84B
| $5.36M | 0.15% |
222,576
+2,646
| +1% | +$65.4K |
2023 Q1
14 quarters
|
|
108
Intuitive Surgical
ISRG
$163B
| $5.33M | 0.15% |
12,467
+5,538
| +80% | +$2.11M |
2025 Q3
4 quarters
|
|
109
iShares iBonds Dec 2035 Term Corporate ETF
IBCA
$410M
| $5.33M | 0.15% |
220,429
+18,817
| +9% | +$470K |
2025 Q4
3 quarters
|
|
110
VanEck Semiconductor ETF
SMH
$62.6B
| $5.3M | 0.14% |
8,972
+109
| +1% | +$62.4K |
2023 Q3
12 quarters
|
|
111
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$48.4B
| $5.3M | 0.14% |
57,936
+716
| +1% | +$65.5K |
2022 Q4
15 quarters
|
|
112
iShares iBonds Dec 2036 Term Corporate ETF
IBCB
$95.5M
| $5.2M | 0.14% |
219,263
+15,578
| +8% | +$382K |
2026 Q2
1 quarter
|
|
113
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.42B
| $5.1M | 0.14% |
241,004
-5,316
| -2% | -$114K |
2021 Q1
22 quarters
|
|
114
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.41B
| $5.08M | 0.14% |
108,828
-13,086
| -11% | -$618K |
2025 Q1
6 quarters
|
|
115
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.04B
| $5.08M | 0.14% |
223,693
-3,087
| -1% | -$70.9K |
2021 Q1
22 quarters
|
|
116
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.15B
| $4.96M | 0.14% |
198,736
-8,409
| -4% | -$211K |
2021 Q1
22 quarters
|
|
117
Chevron
CVX
$412B
| $4.94M | 0.13% |
22,967
+202
| +0.9% | +$39.8K |
2015 Q3
44 quarters
|
|
118
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $4.93M | 0.13% |
60,955
+116
| +0.2% | +$9.44K |
2025 Q3
4 quarters
|
|
119
Sysco
SYY
$38.5B
| $4.93M | 0.13% |
62,642
-1,502
| -2% | -$123K |
2023 Q3
12 quarters
|
|
120
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$4B
| $4.9M | 0.13% |
203,146
-15,123
| -7% | -$365K |
2019 Q1
30 quarters
|
|
121
Citigroup
C
$202B
| $4.85M | 0.13% |
36,789
+3,005
| +9% | +$405K |
2025 Q1
6 quarters
|
|
122
Johnson & Johnson
JNJ
$679B
| $4.81M | 0.13% |
18,233
-443
| -2% | -$117K |
2015 Q3
44 quarters
|
|
123
Western Digital
WDC
$109B
| $4.79M | 0.13% |
12,390
-1,066
| -8% | -$518K |
2025 Q3
4 quarters
|
|
124
Vanguard Dividend Appreciation ETF
VIG
$117B
| $4.78M | 0.13% |
19,910
-376
| -2% | -$90.3K |
2023 Q4
11 quarters
|
|
125
VanEck Emerging Markets Bond ETF
EMBX
$263M
| $4.74M | 0.13% |
95,551
+1,937
| +2% | +$98.5K |
2026 Q1
2 quarters
|
|
Similar funds
Krilogy Financial's Q3 2026 Portfolio in Review
As of Q3 2026, Krilogy Financial held 1,198 positions worth $3.66B, up 8.3% from $3.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Krilogy Financial deployed $234M of net new capital in Q3 2026, opening 127 new positions and adding to 525 existing holdings. Its largest new stake was iShares iBonds Dec 2056 Term Treasury ETF: 1,586,275 shares worth $35.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 62% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $31.3M trimmed.
- Krilogy Financial's largest Q3 2026 buy was iShares iBonds Dec 2056 Term Treasury ETF: 1,586,275 shares worth $35.8M.
- Krilogy Financial added most to SpaceX in Q3 2026, an estimated $110M increase.
- Krilogy Financial's biggest Q3 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $31.3M.
- Krilogy Financial fully exited VanEck Agribusiness ETF in Q3 2026, selling an estimated $9.32M.
- Krilogy Financial's ten largest holdings make up 26% of its $3.66B portfolio in Q3 2026.
- Krilogy Financial opened 127 new positions and closed 115 in Q3 2026.
- Krilogy Financial's portfolio value rose 8.3% quarter-over-quarter to $3.66B.
Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.